It is a crucial step towards enhancing India’s global trade capabilities in the pharmaceutical and medical devices sectors.The Pharmaceuticals Export Promotion Council of India (Pharmexcil) participated in a high-level strategic meeting convened by
Thermo Fisher Scientific announced plans to make significant investments in India’s biopharma infrastructure, with new facilities that will enhance the biopharma manufacturing capabilities. The announcements came when senior executives addressed
.jpeg)
Alcon, the world leader in eye care, announced the commercial launch of its next-generation surgical platforms, the UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) in India. The combined VCS console has been made a...
In a revolutionary stride that will change the landscape of cancer diagnostics in India, Dr. Lal PathLabs (DLPL) has become the first laboratory in the country to implement a deep learning based AI module for the identification of lymph node
Manufacturers are being obliged to destroy stocks in order to comply with a new rule by the Central Drugs Standard Control Organization (CDSCO) that prohibits the export of pharmaceutical items with a shelf life of less than 60%
With investments of over Rs. 54,000 crore in the last year alone, Telangana has once again established itself as a global leader in the life sciences, and the city is currently listed among the top 7 life sciences clusters worldwide
With a focus on finding new RNA-targeting small molecules in specific neurological indications with high unmet medical need, Skyhawk Therapeutics, a leader in the discovery and development of small molecules that modulate RNA expression, announces
Glenmark Pharmaceuticals Inc. is officially announced to implement the launch1 of Micafungin for Injection USP, 50 mg/vial and 100 mg/vial (Single-Dose Vial) from Glenmark Pharmaceuticals Inc., USA (Glenmark)
Hyderabad-based Aurobindo Pharma has accelerated production at its China facility, which was launched in November last year. The company expects the site will achieve EBITDA goal by Q3 FY26, according to CFO Santhanam Subramanian...
A few months ago, I came across the story of an Indian pharmaceutical exporter whose shipment to the US market was rejected at the port. This rejection had nothing to do with product formulation or its manufacturing and safety process...
.jpg)
, CDSCO.jpg)